Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer
1 Clinical Research Unit, Institut Català d’Oncologia, Avinguda Gran Via de l’Hospitalet, 199-203 08907 L’Hospitalet de Llobregat, Barcelona, Spain
2 Department of Medical Oncology, Institut Català d’Oncologia-IDIBELL, L’Hospitalet, Barcelona, Spain
3 Department of Medical Oncology, Hospital General de L’Hospitalet, Barcelona, Spain
4 Department of Radiotherapy, Institut Català d’Oncologia-IDIBELL, L’Hospitalet, Barcelona, Spain
5 Department of Surgery, Hospital Universitario de Bellvitge –IDIBELL, L’Hospitalet, Barcelona, Spain
6 Translational Research Laboratory, Institut Català d’Oncologia-IDIBELL, L’Hospitalet, Barcelona, Spain
7 Department of Pathology, Hospital Universitario de Bellvitge –IDIBELL, L’Hospitalet, Barcelona, Spain